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Background: Maternal alcohol consumption is known to adversely affect fetal neurodevelopment. While it is
known that alcohol dose and timing play a role in the cognitive and behavioral changes associated with prenatal
alcohol exposure, it is unclear what developmental processes are disrupted that may lead to these phenotypes.
Methods: Mice (n=6 per treatment per developmental time) were exposed to two acute doses of alcohol (5 g/kg)
at neurodevelopmental times representing the human first, second, or third trimester equivalent. Mice were reared
to adulthood and changes to their adult brain transcriptome were assessed using expression arrays. These were
then categorized based on Gene Ontology annotations, canonical pathway associations, and relationships to
interacting molecules.
Results: The results suggest that ethanol disrupts biological processes that are actively occurring at the time of
exposure. These include cell proliferation during trimester one, cell migration and differentiation during trimester
two, and cellular communication and neurotransmission during trimester three. Further, although ethanol altered a
distinct set of genes depending on developmental timing, many of these show interrelatedness and can be
associated with one another via ‘hub’ molecules and pathways such as those related to huntingtin and
brain-derived neurotrophic factor.
Conclusions: These changes to brain gene expression represent a ‘molecular footprint’ of neurodevelopmental
alcohol exposure that is long-lasting and correlates with active processes disrupted at the time of exposure. This
study provides further support that there is no neurodevelopmental time when alcohol cannot adversely affect the
developing brain.
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Maternal ethanol consumption is known to be detrimental
to the carefully-organized molecular processes that guide
the neurodevelopment of a fetus. It can lead to a variety of
physiological and neurological consequences, collectively
known as fetal alcohol spectrum disorders (FASDs) [1-3].
Given that approximately one-half of North American
women drink at least occasionally, and that half of all* Correspondence: ssingh@uwo.ca
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reproduction in any medium, provided the orpregnancies are unplanned, it is likely that at least one-
quarter of all infants born have been exposed to alcohol at
least once during gestation [4], making FASD one of the
most common and financially costly sources of develop-
mental disability [5-7]. Further, the effects of prenatal alco-
hol exposure are long-lasting, drastically affecting the
developmental and socioeconomic trajectory of the affected
individual [8-10]. Our understanding of how neurodevel-
opmental alcohol exposure can cause these persistent
changes in cognitive function, however, is not understood.
Most of the existing literature on FASD has focused
on using animal models to understand the immediateLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have shown that ethanol exposure is able to alter gene
expression in the developing brain, both immediately
following acute high-dose exposure [11-13] as well as in
the adult brain following moderate chronic neurodevel-
opmental exposure [14,15] and binge exposures [16,17],
altering genes involved in cell survival, cell signaling,
and neurotransmission. However, these studies often use
variable treatment models with regard to dosage, timing,
and assessment of a given molecular or behavioral pheno-
type, making comparisons between studies difficult. Also,
while these studies often report acute and short-term
changes to the transcriptome, it is less clear what the
long-term consequences of ethanol exposure are and how
exposure may alter neural function across the lifetime of
the exposed individual.
Previously, we have shown that voluntary maternal
ethanol consumption during gestation leads to changes
in brain gene expression in exposed adult mice [15].
While the results identified a number of genes that have
previously been implicated in FASD-relevant neurobe-
havioral phenotypes such as cognitive function, anxiety,
attention deficit hyperactivity disorder, and mood disor-
ders, the effects of this moderate exposure throughout
pregnancy were subtle, making the identification of sta-
tistically significant gene changes, and therefore affected
pathways, challenging. Further, this voluntary maternal
consumption paradigm (consisting of continuous mater-
nal free access to a 10% ethanol solution throughout
gestation) did not allow us to assess the effect of timing
of ethanol exposure on the specific biological processes
that were occurring at each neurodevelopmental stage.
The results do, however, suggest that maternal alcohol
consumption is able to leave a complex ‘footprint’ that
remains long after the cessation of alcohol exposure.
These changes are persistent and alter molecular path-
ways important for adult brain function.
Recently, we have evaluated the effects of a binge-like
ethanol exposure in a C57BL/6J (B6) mouse model at
three specific gestational or postnatal times roughly cor-
responding to the occurrence of human trimesters one,
two, and three [18-20]. This treatment paradigm resulted
in offspring showing many phenotypes relevant to FASD
including delay of achievement of basic neuromuscular
coordination and reflexes, altered activity and anxiety-
related traits, and spatial learning and memory impair-
ments [21]. Interestingly, although the treatments generally
produced similar sets of behavioral changes, a closer exam-
ination of each specific phenotype revealed that their occur-
rence and severity were dependent on the developmental
timing of the ethanol exposure. This follows recent studies
that have started to evaluate the relationship between ex-
posure at various developmental stages and the resulting
phenotypic effects. Behaviorally, it has been found that earlytrimester-three equivalent exposure was more detrimental
to adult trace conditioning than later treatments [22]. Also,
a recent study by Lipinski et al. [23] revealed that small
changes in exposure during early gestation led to differ-
ences in craniofacial morphology in a mouse model of fetal
alcohol syndrome (FAS) that, interestingly, correlated with
specific brain abnormalities.
This study seeks to extend our previous studies evaluat-
ing the long-term consequences of neurodevelopmental
alcohol exposure. Specifically, we investigate the timing
effects of a consistent dose of ethanol administered at the
mouse equivalent of the first, second, or third human tri-
mesters. Our objective is to identify the long-term effects
of disrupting neurobiological processes occurring at these
three times by evaluating the residual pattern of altered
genes, pathways, and gene networks within the adult brain.
We show that there are some common pathways that are
affected by ethanol exposure, regardless of developmental
timing. Also, our data suggest that ethanol exposure tends
to disrupt critical molecular processes that are known to
be actively occurring at each specific developmental time.
These processes remain altered at least into adulthood,
when the behavioral phenotypes that may be driven by
these molecular alterations can affect an individual’s over-
all socioeconomic success [3,9,24]. It is hoped that this
study provides a broad analysis of the long-term molecular
effects of developmental ethanol exposure, and that it al-
lows for a comparison of the susceptibility of particular
processes at three critical neurodevelopment times to alco-
hol teratogenicity.
Methods
Animals and ethanol treatment
All animal protocols were approved by the Animal Use
Subcommittee at the University of Western Ontario
(London, ON, Canada) and complied with the ethical
standards established by the Canadian Council on Ani-
mal Care. C57BL/6J (B6) mice were originally obtained
from Jackson Laboratories (Bar Harbor, ME, USA) and
subsequently maintained at the Health Sciences Animal
Care Facility at the University of Western Ontario. Males
and females were housed in same-sex colonies with ad
libitum access to water and food. Cages and bedding,
including access to environmental enrichment, were stan-
dardized between cages. Colonies were kept in a con-
trolled environment on a 14/10-h light/dark cycle at a
temperature of 21°C to 24°C with 40% to 60% humidity.
Female mice of approximately 8 weeks of age were
time-mated overnight with 8- to 12-week old males. Dur-
ing gestation, dams were housed individually in standard
cages. Six treatment times were selected to approximate
ethanol exposure occurring at the human first, second,
and third trimesters: dam treatment at embryonic days
(E) 8 and 11 (human trimester one equivalent), E14 and
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ment on postnatal days (P) 4 and 7 (human third tri-
mester equivalent) [19,25]. Each mouse (dam or pup) was
treated on two treatment. To model punctuated high-
blood alcohol (binge-like) exposure at these specific
stages, dams (trimesters one and two) or pups (trimes-
ter three) were injected subcutaneously with 2.5 g/kg of
ethanol in 0.15 M saline at 0 h and 2 h. This method has
been previously reported and induces a peak blood alcohol
level of over 0.3 g/dl for 4 to 5 h following injection,
and is sufficient to induce neuronal apoptosis and result
in FASD-related behaviors [21,26,27]. Control dams and
pups were injected with saline alone, and where pos-
sible, mice were matched across treatments for weight.
Pups were weaned into same-sex colonies of two to four
mice at P21 to P25 and raised under standard housing
conditions.RNA isolation and microarray hybridization
At P60, male offspring from the above treatment models
were sacrificed by carbon dioxide asphyxiation and
whole brain tissue (all structures including the olfactory
bulb to the medulla) was isolated, snap-frozen in liquid
nitrogen, then stored at -80°C until RNA isolation. Total
RNA was isolated using TrizolW (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions
and cleaned using RNeasy Mini kit (QIAGEN, Valencia,
CA, USA). The quality and quantity of RNA was assessed
using the Agilent 2100 Bioanalyzer (Agilent Technologies
Inc., Palo Alto, CA, USA) and a NanoDrop ND-1000 spec-
trophotometer (Thermo Fisher Scientific Inc., Wilmington,
DE, USA). Each biological replicate consisted of equal
quantities of RNA from three non-littermate males pooled
to reduce litter effects. Two biological replicates per treat-
ment group were used (n=12 mice per treatment time). All
RNA labeling and hybridization steps were performed at
the London Regional Genomics Centre (Robarts Research
Institute, London, ON, Canada). Briefly, single-stranded
complementary DNA (sscDNA) was synthesized using 200
ng of total RNA using the Ambion WT Expression Kit for
Affymetrix GeneChip Whole Transcript WT Expression
Arrays (Applied Biosystems, Carlsbad, CA, USA) and the
Affymetrix GeneChip WT Terminal Labeling kit and hy-
bridization manual (Affymetrix, Santa Clara, CA, USA).
First-cycle cDNA was transcribed in vitro to cRNA, and
used to synthesize 5.5 μg of sscDNA that was subsequently
end-labeled and hybridized for 16 h at 45°C to Affymetrix
Mouse Gene 1.0 ST arrays. For each treatment time, arrays
(two control and two ethanol-exposed) were used for a
total of 12 arrays. Liquid-handling steps were performed by
a GeneChip Fluidics Station 450 and arrays were scanned
using the GeneChip Scanner 3000 using Command Con-
sole v1.1 (Affymetrix, Santa Clara, CA, USA).Microarray data analysis
Probe level (.CEL) data were generated using Affymetrix
Command Console v1.1 and probes were summarized to
gene-level data using Partek Genomics Suite software
v.6.6 (Partek Inc., St. Louis, MO, USA). Array data from
all treatment times (12 arrays) were included in a single
analysis. Data were background corrected, quantile-
normalized, summarized using the GeneChip-Robust
Multiarray Averaging (GC-RMA) algorithm to take into
account probe GC-content [28], and log2-transformed. The
Partek Suite was also used to determine gene-level ANOVA
P values and fold changes. Given that prenatal ethanol
exposure produces mostly subtle long-term changes in
gene expression [15], genes meeting the criteria of a 1.2-fold
change with a FDR-corrected P value <0.05 were consid-
ered for further analysis. Unannotated genes and standards
were removed from the gene lists used for clustering and
pathway analyses. These significant genes were subjected
to hierarchical clustering analysis using Euclidean distance
and average linkage to assess the consistency across rep-
licates and to evaluate the general trends in changes to
gene expression across each treatment. All data files from
the array experiments have been deposited in the Natio-
nal Center for Biotechnology Information Gene Expres-
sion Omnibus and can be found under the accessions
GSE34469 and GSE34549. Complete lists of differentially
expressed genes identified for each of the three treatments
are given in Additional file 1: Table S1.
Gene ontology and gene network analysis
To evaluate genes and processes that may be involved in
a general ethanol response regardless of developmental
timing, a list containing genes that were differentially ex-
pressed across multiple treatments was generated. This list
was analyzed using the functional annotation and cluster-
ing software tool available through the online Database
for Annotation, Visualization and Integrated Discovery
(DAVID) Bioinformatics Resources v.6.7 [29,30]. Gene
Ontology (GO) terms and Swiss-Prot and Protein Infor-
mation Resource (SP PIR) keywords were used to cluster
genes. Non-redundant terms with P <0.05 were reported.
To identify over-represented GO terms associated with
genes showing altered expression for individual trimester
treatments, Ingenuity Pathway Analysis v.9 (IPA) (Ingenuity
Systems, Redwood, CA, USA; www.ingenuity.com) was
used to cluster genes based on biological function. Average
fold-change and P values of each gene were included in the
analysis. As most genes identified were downregulated, both
up- and downregulated genes were assessed concurrently.
Redundant GO categories (those containing the same mole-
cules with closely related functions) were removed. Bio-
logical functions annotations with a P <0.05 were included.
IPA was also used to generate gene networks between
genes possessing annotated functional relationships with
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a cutoff significance score of 3 or more (P <0.001) were
reported.
Quantitative RT-PCR
RNA extracts not used for array hybridization were used
to confirm the expression of selected genes by real-time
RT-PCR. Complementary DNA (cDNA) was synthesized
using 2 μg of total brain RNA using a High-Capacity
cDNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA, USA) according to the manufacturer’s
protocol. Gene-specific TaqManW Assay Reagents and
TaqMan Gene Expression Assay products were used on
a StepOne Real Time PCR System (all Applied Biosystems,
Foster City, CA, USA). Primers and FAM-labeled probes
for Tnfrsf19 (E8/11) Cdkn1a, Manf, Htr5a (E14/16), Cnr1,
and Grin2b (P4/7) were obtained from Applied Biosystems
Inventoried Assays and used as per the manufacturer’s
instructions. These genes were selected on the basis of
their functional relevance to cell stress and survival path-
ways (Cdkn1a, Tnfrsf19) or neurological function (Manf,
Htr5a, Grin2b, Cnr1). Reactions were multiplexed with
Gapdh using gene-specific primers and a VIC-labeled
probe. Reactions were run following a standard ramp
speed protocol using 10 μLvolumes. PCR cycling consisted
of a 10 min initiation at 95°C, followed by 40 cycles
consisting of a 15 s denaturation at 95°C and an anneal
and extension at 60°C for 60 s. All experiments included
six biological replicates per treatment and three technical
replicates per sample. Relative expression was calculated
according to the comparative CT method [31] using
StepOne™ v2.0 software (Applied Biosystems) and ana-
lyzed using SPSS v.16 (SPSS Inc., Chicago, IL, USA). All
PCR data are reported as mean ± SEM relative expression
values. Significant differences were assessed using a stu-
dent’s t-test using SPSS v.16 (SPSS Inc, Chicago, IL, USA).
Results
Neurodevelopmental timing of ethanol exposure dictates
the pattern of gene expression changes in the adult brain
We first assessed the overall patterns of gene expression
in three groups of adult (P60) mice subjected to binge-
like ethanol exposures at E8 and 11 (E8/11) (first human
trimester equivalent), E14 and 16(E14/16) (second hu-
man trimester equivalent), or P4 and 7 (P4/7) (third hu-
man trimester equivalent) by performing a hierarchical
clustering analysis of the signal ratios of all arrays. The
heat map representing array clustering based on normal-
ized probe intensity showed that the control chips cluster
closely despite some inter-individual variation, as expected
(Figure 1). The results also showed that the pattern of
adult brain gene expression following ethanol exposure
during the three developmental times was variable and
dependent on the timing of the treatment, as evidencedby the distinct branches for each treatment paradigm.
Neurodevelopmental ethanol exposure at E8/11, E14/16,
and P4/7 resulted in the altered expression of 195 genes,
231 genes, and 336 genes, respectively (fold change >1.2,
FDR-corrected P <0.05) in the adult brain. These changes
ranged from a +3.3-fold increase from matched controls
(Proline rich protein 2 following P4/7 treatment) to -3.2-
fold decrease (Stomatin (Epb7.2)-like 3 following E14/16
treatment). Further, the distribution of up- and down-
regulated genes were not equal with only 61 genes (31%),
54 genes (23%), and 15 genes (4%) showing increased ex-
pression as compared to controls following ethanol treat-
ment at E8/11, E14/16, and P4/7, respectively. There was
also little overlap between genes altered across the three
treatment times (Figure 2) with 82%, 88%, and 89% of the
genes affected specific to a single one treatment time.
Also, 48 genes were found to be altered by at least two
treatments, with four (Gmze, Hsf1, Rhog, Trdn) altered by
ethanol exposure by all three (Table 1, Figure 2). Full gene
lists can be found in Additional file 1: Table S1.
Real-time PCR validation of array results
We chose to confirm the changes in expression of five
genes altered by ethanol exposure identified by the array
experiments using real-time PCR to validate our array re-
sults. The real-time results and microarray fold-changes for
the five genes are shown in Figure 3. For E8/11, the
downregulation of tumor necrosis factor receptor super-
family, member 19 (Tnfrsf19) was confirmed (P = 0.024).
We were also able to confirm the downregulation of cyclin-
dependent kinase inhibitor 1A (P21) (Cdkn1a) (P = 0.019)
and mesencephalic astrocyte-derived neurotrophic factor
(Manf) (P = 0.024), both shown to be differentially ex-
pressed following ethanol treatment at E14/16. We were
not able to confirm the downregulation of Htr5a by quanti-
tative PCR (P >0.05). We also evaluated the expression of
cannabinoid receptor 1 (brain) (Cnr1) and glutamate re-
ceptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), both
downregulated following ethanol treatment at P4/7. Real-
time results confirmed the array results with both Cnr1
(P = 0.0042) and Grin2b (P = 0.014) genes showing statisti-
cally significant downregulation.
Functional annotation analysis of genes affected by
ethanol treatment
Functional clustering analysis was performed using the
48 genes altered by more than one treatment paradigm
(Table 1) to assess potentially common processes af-
fected by neurodevelopmental alcohol exposure, regard-
less of timing. Genes were evaluated together in a single
analysis using the Database for Annotation, Visualization
and Integrated Discovery (DAVID ) v6.7 [29,30], which
returned three significant functional annotation clusters.
Most significant was the GO biological process (BP)
Figure 1 Heat map representing hierarchical clustering of arrays based on the normalized intensity of the probe sets. Control and
ethanol-treated samples are indicated (n=2), with each replicate consisting of RNA pooled from three male mice obtained from six litters.
Treatment times are also indicated. Heat map was generated by PartekW Genomics Suite software based on ANOVA-calculated significance levels
at a fold-change cutoff of 1.2 and a FDR-corrected P value <0.05.
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Egln3, Gzme, Map3k1, Mef2d, Pglyrp1, and Sra1. Also
significant were genes associated with the SP PIR key-
word ‘methylation’ (P = 0.011), consisting of Hist1h2bm,
Hist1h3c, Ubc, and Rhog, and the GO BP term ‘positive
regulation of gene expression’ (P = 0.021), consisting of
Iltifb, Ntf3, Rhog, Sra1, and Tnfsf13b.Gene enrichment analysis identifies that alterations to
genetic processes caused by neurodevelopmental ethanol
are exposure-stage dependent
The gene lists generated from each individual treatment
model were subjected to GO analysis to evaluate over-
represented molecular functions and biological processes
using the ‘core analysis’ function within the IPA software
Figure 2 Venn diagram indicating the number of differentially
expressed genes identified by each treatment paradigm (E8/11,
E14/16, P4/7), including the number of genes that overlapped
between multiple treatments.
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this analysis indicating the most significant non-
redundant GO categories and ‘functions annotations’ are
shown in Table 2. The GO terms significantly associated
with genes disrupted by ethanol treatment at E8/11 sug-
gested a disruption in processes associated with cellu-
lar organization, cellular development, and cell death. The
functions annotations associated with these GO categories
indicate that mice exposed to ethanol at E8/11 may have
deficits related to quantity of neurons and abnormal axon
development, potentially leading to altered synaptic func-
tion. Interestingly, most of these GO gene enrichment clus-
ters were driven by the presence of neurotrophin 3 (Ntf3).
The significant GO categories identified in adult mice
treated with ethanol at E14/16 involved changes to mole-
cules involved in cellular movement, cell death, and cell
morphology (Table 2). In contrast to the E8/11 treatment
results, which suggested changes to processes involved in
cellular survival and proliferation, the functions annota-
tions associated with these GO categories suggested that
these mice may show alterations related to neuronal mi-
gration and differentiation. These categories appeared to
be driven by the altered expression of doublecortin (Dcx)
and distal-less homeobox 1 and 2 (Dlx1, Dlx2). Interest-
ingly, similarly to the cell death annotation in the E8/11
exposure, the ‘cell death’ function identified in the E14/16
paradigm was also driven by heat shock factor 1 (Hsf1).
The GO categories associated with genes altered by
exposure at P4/7 were primarily associated with cell-cell
signaling and communication, with alterations to geneswhose functions included roles in synaptic formation, trans-
mission, depression, and plasticity. Further, alterations to a
number of molecules involved in steroid-mediated cell
communication (such as glucocorticoids) were identified,
as were changes in genes involved in the gliosis of the
hippocampus. These molecular functions suggest that P4/7
ethanol exposure may significantly alter the synaptic func-
tion and structure of the adult brain. The molecules that
show altered expression following P4/7 exposure support
this, with changes to a number of critical neurotransmitter-
related systems such as glutamate (Grik1, Grin2b, Grm4),
serotonin (Htr1a), cannabinoids (Cnr1) and ephrins (Ephb1,
Ephb2). Also notable is the altered regulation of apolipopro-
tein E (Apoe) and propriomelanocortin (Pomc) given their
roles in the development and function of the hypothalamic-
pituitary-adrenal (HPA) axis.
Canonical pathways affected by neurodevelopmental
ethanol exposure
Using IngenuityW software, we also evaluated the canon-
ical pathways that may be altered as a result of each etha-
nol treatment. E8/11 exposure was associated with the
endoplasmic reticulum stress pathway, xenobiotic metab-
olism signaling, and, interestingly, glucocorticoid receptor
signaling (Table 3). Also significant were phospholipase C
signaling, antiproliferative role of somatostatin receptor 2,
and calcium signaling. The identification of these path-
ways as significantly altered support that E8/11 exposure
may disrupt general systems that have a pleiotropic devel-
opmental function. Canonical pathways associated with
E14/16 exposure were fatty acid biosynthesis, serotonin
receptor signaling, and regulation of actin-based motility
by Rho (Table 3). These results are consistent with the
gene ontology results and support that ethanol exposure
during E14/16 may result in the long-term disruption
of genes associated with brain cell proliferation and mi-
gration processes, as well as some cell-communication
functions. Finally, P4/7 exposure was most significantly
associated with alterations in molecules involved in glu-
tamate receptor signaling (Table 3), also supporting the
P4/7 GO results. Other developmentally-associated Ca-
nonical Pathways identified were retinoic acid-mediated
apoptosis signaling, ephrin receptor signaling, and, inter-
estingly, Circadian rhythm signaling, which was driven by
the alterations to a number of glutamate receptor subunits
(Grin2b, Grin3b, Grin2c, and Grin2d). P4/7 ethanol expo-
sure also was associated with changes to the one carbon
pool by folate and mTOR signaling pathways.
Network analysis shows common interacting molecules
regardless of developmental timing of ethanol exposure
Using the network analysis tool within the IngenuityW
software platform, we predicted interacting molecular
networks to further evaluate the broader potential effects
Table 1 Common genes altered in the adult (P60) brain by different ethanol treatments during neurodevelopment
Accession no. Gene
symbol
Gene name Chr. Fold change per treatment timea
E 8/11 E 14/16 P 4/7
NM_019816 Aatf Apoptosis antagonizing transcription factor 11 B5 -1.20 ns -1.32
NM_001190371 Ankrd29 Ankyrin repeat domain 29 18 A1 -1.24 -1.2 ns
NM_145990 Cdk5rap2 CDK5 regulatory subunit associated protein 2 4 C2 -1.26 NS -1.26
NM_198019 Cep78 Centrosomal protein 78 19 A ns -1.22 -1.37
NM_133840 Clp1 Cleavage and polyadenylation factor I subunit,
homolog (S. cerevisiae)
2 D ns -1.21 -1.2
NM_027468 Cpm Carboxypeptidase M 10 D2 -1.29 1.28 ns
NM_001163026 Dnajc13 DnaJ (Hsp40) homolog, subfamily C, member 13 9 F1 ns 1.24 -1.21
NM_008929 Dnajc3 DnaJ (Hsp40) homolog, subfamily C, member 3 14 E4 -1.21 ns -1.38
NM_028133 Egln3 EGL nine homolog 3 (C. elegans) 12 C1 ns -1.28 1.41
NM_153782 Fam20a Family with sequence similarity 20, member A 11 E1 -1.24 1.21 ns
NM_010240 Ftl1 Ferritin light chain 1 7 B4 -1.26 ns -1.51
NM_001166065 Gcnt4 Gcnt4 glucosaminyl (N-acetyl) transferase 4,
core 2 (beta-1,6-N-acetylglucosaminyltransferase)
13 D1 ns -1.24 -1.44
NM_011937 Gnpda1 Glucosamine-6-phosphate deaminase 1 18 B3 -1.21 ns -1.48
NM_001013385 Grm4 Glutamate receptor, metabotropic 4 17 A3 -1.33 ns -1.38
AK138760 Gtf3c2 General transcription factor IIIC, polypeptide 2, beta 5 B1 -1.33 1.37 ns
NM_010373 Gzme Granzyme E 14 C3 1.28 -1.21 -1.21
NM_173400 Haus6 HAUS augmin-like complex, subunit 6 4 C4 1.2 ns -1.42
NM_175256 Heg1 HEG homolog 1 (zebrafish) 16 B3 -1.2 ns -1.23
NM_178200 Hist1h2bm Histone cluster 1, H2bm 13 A2-3 ns 1.27 -1.53
NM_175653 Hist1h3c Histone cluster 1, H3c 13 A2-3 -1.31 ns -1.3
NM_001024720 Hmcn1 Hemicentin1 1 G1 1.2 ns -1.28
NM_008296 Hsf1 Heat shock factor 1 15 D3 -1.25 1.22 -1.22
NM_054079 Iltifb Interleukin 10-related T cell-derived inducible factor beta 10 D2 -1.22 ns -2.2
NM_201531 Kcnf1 Potassium voltage-gated channel, subfamily F, member 1 12 A1.1 -1.31 -1.21 ns
NM_172871 Klhl9 Kelch-like 9 (Drosophila) 4 C4 ns -1.21 -1.31
NM_011945 Map3k1 Mitogen-activated protein kinase kinase kinase 1 13 D2 ns -1.2 -1.5
BC132343 Mars2 Methionine-tRNA synthetase 2 (mitochondrial) 1 C1 ns -1.22 -1.62
ENSMUST00000001455 Mef2d Myocyte enhancer factor 2D 3 F1 -1.21 ns -1.26
NR_029580 Mir194-1 microRNA 194-1 1 1.22 ns 1.5
NM_028901 Myo18b Myosin XVIIIb 5 F 1.26 -1.26 ns
NM_153578 Nipa1 Non-imprinted in Prader-Willi/Angelman syndrome 1
homolog (human)
7 C -1.28 ns -1.22
NM_001164035 Ntf3 Neurotrophin 3 6 F3 -1.41 ns -1.58
NM_178668 Pde12 Phosphodiesterase 12 14 A3 ns -1.22 1.25
NM_009402 Pglyrp1 Peptidoglycan recognition protein 1 7 A3 −1.31 ns −1.31
NM_001081307 Ppp1r12b Protein phosphatase 1, regulatory (inhibitor) subunit 12B 1 F ns -1.21 -1.29
NM_031499 Prp2 Proline rich protein 2 6 G1 1.68 ns 3.3
NM_029614 Prss23 Protease, serine, 23 7 E1 1.22 -1.21 ns
NM_019566 Rhog Ras homolog gene family, member G 7 F1 -1.22 1.21 -1.48
NM_146118 Slc25a25 Solute carrier family 25 (mitochondrial carrier,
phosphate carrier), member 25
2 B -1.21 ns -1.35
AF357427 Snord115 Small nucleolar RNA, C/D Box 115 cluster 7 ns 1.23 1.71
NR_028275 Snord14e Small nucleolar RNA, C/D box 14E 9 1.26 -1.27 ns
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(Continued)
NM_025291 Sra1 Steroid receptor RNA activator 1 18 B2 -1.27 -1.22 ns
NM_033622 Tnfsf13b Tumor necrosis factor (ligand) superfamily,
member 13b
8 A1 1.21 ns -1.23
NM_029726 Trdn Triadin 10 A4 1.27 -1.61 -2.21
BC025894 Ubc Ubiquitin C 5 G1 ns 1.29 -1.34
NM_016982 Vpreb1 Pre-B lymphocyte gene 1 16 A3 1.46 -1.28 ns
NM_172643 Zbtb41 Zinc finger and BTB domain containing 41 homolog 1 F -1.22 ns -1.32
NM_028543 Zfp763 Zinc finger protein 763 17 B1 -1.29 -1.26 ns
aE, embryonic day; P, postnatal day; ns, not significantly different.
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of adult neurological systems. These analyses suggested
that related regulatory and/or effector pathways are asso-
ciated with ethanol exposure regardless of timing, as well
as highlighted some differences that may be associated
with timing-specific physiological or behavioral FASD-
associated abnormalities.
Analysis of the molecules altered following E8/11 expos-
ure revealed two significant interacting gene networks
related to ‘Neurological Disease, Psychological Disorders,
and Cell Morphology’ (NPC) with 18 focus molecules,
and ‘Organismal Development, Nutritional Disease, and
Behavior’ (ONB) with 13 focus molecules extracted from
the differentially expressed genes (Figures 4A and B). The
NPC network identified a number of molecules related to
glutamate signaling although the receptor subunit genes
themselves were not differentially expressed. The ONB
network indicated the significant interaction of altered
genes with the immediate early transcription factor, FBJ
murine osteosarcoma viral oncogene homolog (Fos), and,Figure 3 Quantitative PCR confirmation of genes identified as altered
analysis. Expression values are shown as a ratio of the control value ± SEM
biological replicates, each consisting of the RNA from three non-littermate
biological replicates consisting of the RNA from six ethanol-exposed males
using unpaired t-tests. All bars are significantly different from their respecti
Htr5a (P >0.05) and therefore this gene is not included in this figure.interestingly, three upregulated microRNAs (miRNAs).
Given that these two networks contained a number of
overlapping genes, the networks were merged to produce
a broader view of the molecules that linked the genes al-
tered by E8/11 ethanol exposure (Figure 4C). The merged
networks revealed several ‘hub’ molecules including amyl-
oid beta (A4) precursor protein (App), brain-derived
neurotrophic factor (Bdnf), Fos, huntingtin (Htt), and
tumor protein p53 (Tp53).
Network analysis of genes altered by E14/16 exposure
revealed similarities to the E8/11 exposure results, sug-
gesting some common effector molecules may act in re-
sponse to ethanol exposure regardless of developmental
timing. The most significant network functions were ‘Cel-
lular Development, Nervous System Development and
Function, Behavior’ (CNB), with 14 focus molecules, and
‘Neurological Disease, Cell Death, and Psychological Dis-
orders’ (NCP), also with 14 focus molecules (Figures 5A
and B). Again, Htt and Fos appeared as hub molecules
within the CNB network, as well as Jun proto-oncogeneby neurodevelopmental ethanol exposure by microarray
. Microarray values represent the results of ANOVA comparison of two
male mice. Quantitative PCR values were generated using six
mice. Significance differences from control values were determined
ve controls (P <0.05). We were unable to confirm the expression of
Table 2 Significant gene ontology (GO) categories and molecular functions annotations for genes differentially
expressed in the brain of adult (P60) mice neurodevelopmentally exposed to ethanol
Timing of treatmenta GO category Functions annotation P value Molecules
E 8/11 Cellular assembly and organization Extension of axons 0.0082 Dclk1, Ntf3, Tnfrsf12a
Protein synthesis Translation of protein 0.0025 Eif2s1, Hspa5
Cell-to-cell signaling and interaction Synaptic transmission 0.0136 Egr3, Ntf3
Tissue development Accumulation of cells 0.0153 Cdkn1a, Ntf3
Cell death Cell death of sensory neurons 0.0171 Hsf1, Ntf3
Tissue morphology Quantity of interneurons 0.0250 Dclk1, Ntf3
E 14/16 Cellular movement Migration of interneurons 0.00013 Dcx, Dlx1, Dlx2
Tissue development Development of olfactory bulb 0.0168 Dlx2, Nr2e1
Cellular development Differentiation of neuronal
progenitor cells
0.0214 Dlx1, Dlx2
Cell death Cell death of sensory neurons 0.0238 Bok, Hsf1
Neurological disease Neurodegenerative disorder 0.0458 Cav1, Cox1, Dcx, Htr6, Pcna
Cell morphology Shape change of neurons 0.0473 Dcx, Hcrt
P 4/7 Cell-to-cell signaling and interaction Synaptic transmission 0.00014 Apoe, Chrm1, Cnr1, Ephb2, Grik1,
Grin2b, Htr1a, Nrgn1, Ntf3
Lipid metabolism Secretion of steroid 0.0018 Apoe, Pomc
Cell-to-cell signaling and interaction Synaptic depression 0.0133 Chrm1, Cnr1, Ephb1, Grin2b, Htt
Cell-to-cell signaling and interaction Plasticity of synapse 0.0144 Apoe, Grik1, Grin2b, Htt, Inppl1, Syngap1
Cell morphology Formation of cellular protrusions 0.0329 Apoe, Dst, Efna5, Efnb2, Egfr, Ephb1,
Grm4, Htt, Kif23, Nbl1, Ntf3, Ntng2,
Pcdh15, Rhog, Syne1, Syngap1, Wnt3a
Cellular development Proliferation of neuronal cells 0.0366 Cnr1, Irx5, Mycn, Nbn, Ntf3, Wnt3a
Neurological disease Gliosis of hippocampus 0.0400 Apoe, Htt
aE, embryonic day; P, postnatal day.
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tion factor Activator protein 1 (Ap-1). App once again
formed a main hub within the NCP network, and Fos and
Tp53 appeared within this network similarly to the net-
works generated from the E8/11 data. Merging of these
two networks revealed App, Fos, and Htt as major hubs
once again (Figure 5C). Other major hubs unique to the
E14/16 treatment paradigm included notch signaling, Jun,
and the cell-cycle transcription factor E2f1.
Network analysis of P4/7 ethanol exposure resulted in
gene networks that included some molecules common
to the E8/11 and E14/16 analyses, many of which showed
altered expression in this treatment model. The two most
significant associated network functions were ‘Neurological
disease, Cell Death, Psychological Disorders’ (NCP) with
17 focus molecules and ‘Cell Morphology, Cell-To-Cell
Signaling and Interaction, Nervous System Development
and Function’ (CCN) with 14 focus molecules (Figures 6A
and B). These network functions support the results of
the gene ontology and pathway analysis, suggesting that
P4/7 exposure may result in altered cell-cell communica-
tion and synaptic function, as well as alterations to intrinsic
apoptosis cascade proteins. The NCP network contained
Htt as a hub molecule, similar to both E8/11 and E14/16treatment networks, which was identified as downregu-
lated in the adult brain following P4/7 ethanol treatment.
Other hub molecules included glutamate receptor, iono-
tropic, N-methyl D-aspartate 2B (Grin2b) and the apop-
tosis enzyme Caspase 3 (Casp3), both of which were also
downregulated. The CCN network also contained a num-
ber of glutamate receptor subunits with Grin2b acting as a
network hub molecule connecting multiple interacting
genes. Other hub molecules included the synaptic protein
discs, large homolog 4 (Drosophila) (Dlg4) and retinoic
acid receptor, alpha (Rara). The merged networks again
suggest Htt as a central hub connecting multiple mole-
cules (Figure 6C), as well as the glutamate receptor pro-
teins Grin2b and glutamate receptor, ionotropic, AMPA1
(alpha 1) (Gria1). Neurotrophin 3 (Ntf3), identified as dif-
ferentially expressed in the adult brain following ethanol
treatment at E8/11, was also downregulated by ethanol
treatment at P4/7 and appeared as a hub within the
merged gene networks, as did apolipoprotein E (Apoe).
Discussion
The development of the brain is highly orchestrated, co-
ordinated by proper gene expression in response to de-
velopmental cues and in response to the environment. It
Table 3 IngenuityW canonical pathways significantly associated with genes altered in the adult (P60) brain by
neurodevelopmental alcohol exposure
Timing of treatmenta IngenuityW canonical pathway P value Molecules
E 8/11 Endoplasmic reticulum stress pathway 0.00003 Xbp1, Dnajc3, Eif2s1, Hspa5
Xenobiotic metabolism signaling 0.00282 Sra1, Ftl, Nras, Map3k13, Camk1g,
Cyp2c19, Ncor2, Mapk11
Glucocorticoid receptor signaling 0.00501 Sra1, Nras, Hpsa1a, Taf5l, Cdkn1a,
Ncor2, Hspa5, Mapk11
Phospholipase C signaling 0.00741 Rhog, Nras, Mef2d, Myl4, Gng13,
Rapgef3, Itga4
Antiproliferative role of somatostatin receptor 2 0.0263 Nras, Cdkn1a, Gng13
Calcium signaling 0.0269 Calr, Mef2d, Trdn, Camk1g, Myl4
E 14/16 Fatty acid biosynthesis 0.00363 Oxsm, Mcat
Serotonin receptor signaling 0.00603 Htr5a, Htr3a, Htr6
Regulation of actin-based motility by Rho 0.0145 Myl9, Rhog, Rnd3, Ppp1r12b
P 4/7 Glutamate receptor signaling 0.000007 Grin2b, Grin3b, Gnb3, Grid1, Grin2c,
Grin2d, Grik3, Grm4, Grik1
Retinoic acid-mediated apoptosis signaling 0.00055 Fadd, Casp3, Rarb, Tnfsf10, Rxrb, Irf1
Ephrin receptor signaling 0.00224 Frin2b, Efnb2, Ephb1, Grin3b, Gnb3,
Itsn1, Grin2c, Efna5, Grin2d, Vegfc, Figf
Circadian rhythm signaling 0.00692 Grin2b, Grin 3b, Grin2c, ,Grin2d
One carbon pool by folate 0.00794 Tyms, Mthfs, Mtr
mTOR signaling 0.0288 Fau, Rhog, Rps10, Rptor, Vegfc,
Figf, Insr, Rpsa
aE, embryonic day; P, postnatal day.
Kleiber et al. Journal of Neurodevelopmental Disorders 2013, 5:6 Page 10 of 19
http://www.jneurodevdisorders.com/content/5/1/6is also a remarkably vulnerable target for a variety of drugs
of abuse, particularly ethanol [32,33]. This vulnerability
leads to changes in brain structure and function, resulting
in the long-term behavioral and cognitive changes that
characterize FASD [1,3,34-36]. The manifestation and se-
verity of specific FASD phenotypes, however, varies widely
across individuals prenatally exposed to ethanol for rea-
sons that are not entirely clear. Further, while it is known
that developmental ethanol exposure leads to changes
in neural molecular architecture, including changes to
genome-wide gene expression [11,12,15]), how these alter-
ations are initiated, maintained over time, and relate to
specific FASD-relevant neurological phenotypes remains
unknown. The results included in this report focus on the
pattern of long-term changes in brain gene expression in
adult B6 mice following ethanol exposure at three neuro-
developmental times corresponding to the approximate
human equivalent of trimesters one, two, and three.
In a previous experiment, we have determined that the
exposure paradigms used in this study (binge-like treat-
ments at developmental days representing early, mid, and
late human gestational neurodevelopmental exposure) re-
sult in behavioral phenotypes that are relevant to the abnor-
malities observed in individuals with FASD [21]. This study
seeks to extend these findings by evaluating the genes and
their associated pathways that show long-term disruptiondue to prenatal alcohol exposure. We do acknowledge that
the neurodevelopmental timelines in rodents and humans
are similar but not identical, particularly the period of
synaptogenesis that occurs during the third trimester and
extends postnatally in humans but occurs primarily postna-
tally in mice [19,37]. Also, due to these differences, two of
the treatment models (ethanol exposures at E8/11 and E14/
16) represent maternal treatments whereas mouse pups
were administered ethanol in the trimester three model
(exposure at P4/7). This may result in differences in total
blood alcohol levels achieved, which is a caveat of these
methods, although there is evidence that ethanol rapidly
crosses across the placental barrier and can appear within
the embryo within 5 minutes after maternal treatment
[38]. Regardless of these potential differences in blood alco-
hol levels achieved, the results obtained using this mouse
model may be an effective means to parse the long-term
consequences of fetal alcohol exposure to the developing
brain [18,39].
Ethanol-induced long-term changes to gene expression
are subtle, multifactorial, and timing-dependent
The clustering of gene expression signal intensities of the
arrays representing the control and ethanol-treated sam-
ples (Figure 1) suggested that alcohol exposure during
neurodevelopment significantly altered the transcriptome
Figure 4 Ingenuity pathway analysis (IPA) network analysis indicating annotated interactions between genes affected in the adult
brain by ethanol exposure at E8 and 11. Up- (red) and down- (green) regulated genes are indicated. Significant networks identified, as well as
their IPA functional category, are shown in (A) and (B). (C) Merged image of networks shown in (A) and (B) showing the interrelatedness of the
genes involved. Centralized ‘hub’ molecules linking multiple interacting genes are enlarged.
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ferences were not assessed in this study and although we
and others have previously observed that minor, if any, al-
terations to maternal care occur following gestational alco-
hol exposure [40-42], these finding are predominantly
based on voluntary maternal consumption paradigms and
not binge-like exposures. It is possible, then, that maternal
care differences between ethanol-treated and control dams
may contribute to the observed gene expression differences.However, there was very little overlap between the genes
identified by each of the ethanol-treatment times (Table 1,
Figure 2), suggesting that a major contributor to the set of
genes affected was the timing of exposure. This may be at-
tributed to the considerable changes that occur to the brain
transcriptome across development, resulting in a different
repertoire of processes on which ethanol may act and lead-
ing to a very different footprint of genes that remain altered
into adulthood.
Figure 5 Ingenuity pathway analysis (IPA) network analysis indicating annotated interactions between genes affected in the adult
brain by ethanol exposure at E14 and 16. Up- (red) and down- (green) regulated genes are indicated. Significant networks identified, as well
as their IPA functional category, are shown in (A) and (B). (C) Merged image of networks shown in (A) and (B) showing the interrelatedness of
the genes involved. Centralized ‘hub’ molecules linking multiple interacting genes are enlarged.
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alcohol exposure may reflect predominant biological
processes occurring at the time of exposure
The results included in Table 1 and Figure 2 show that
only a small number of genes were altered by ethanol by
multiple treatment models. In general, these genes rep-
resent pleiotropically-acting molecules associated withcell death, regulation of gene expression, and, interest-
ingly, methylation. Such results may argue that the most
common and timing-independent response to alcohol is
cellular stress, potentially leading to apoptosis at the
time of exposure. The long-term changes to these genes
may suggest that the surviving cells retain a ‘memory’ of
exposure and may show altered response to subsequent
Figure 6 Ingenuity pathway analysis (IPA) network analysis indicating annotated interactions between genes affected in the adult
brain by ethanol exposure at P4 and P7. Up- (red) and down- (green) regulated genes are indicated. Significant networks identified, as well as
their IPA functional category, are shown in (A) and (B). (C) Merged image of networks shown in (A) and (B) showing the interrelatedness of the
genes involved. Centralized ‘hub’ molecules linking multiple interacting genes are enlarged.
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ethanol exposure can result in heightened ‘sensitization’
of adult neurons to ethanol [43,44], which may be a con-
tributing factor to fetal alcohol exposure and increased
risk for alcohol abuse [45]. These genes, however, repre-
sent only a small proportion of the genes detected,
which suggests that the effect of developmental alcohol
exposure may be dictated by the interaction betweenethanol and the specific biological processes occurring at
the time of exposure.
Ethanol exposure during trimester one alters genes
associated with tissue morphology
We performed GO analysis on the gene lists generated
by each treatment model (E8/11, E14/16, and P4/7) in
order to identify the overrepresented biological functions
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each of the three treatments showed relevance to pre-
dominant biological processes occurring at the develop-
mental stage of exposure. For example, E8/11 exposure
was associated with alterations to genes involved in cel-
lular assembly, proliferation, differentiation, cell death,
and tissue morphology (Table 2), even in the adult brain.
Developmentally, ethanol-induced disruptions in deci-
sions regarding the ‘accumulation of cells’ and ‘quantity
of interneurons’ during early gestation could lead to al-
terations in the number of cells that exist in certain
brain regions, perhaps through inhibition of mitosis or
by promoting inappropriate apoptosis, but it is unclear
what effect the alteration of these genes may have in the
adult brain. The significant functions annotations for tri-
mester one exposure appear to be driven primarily by
the altered expression of Neurotrophin 3 (Ntf3). Disrup-
tions in Ntf3 expression during development are detrimen-
tal given its canonical role as a neuronal survival factor
[46,47] and regulator of axonal growth and guidance, syn-
aptic structure, and synaptic plasticity [48-51]. In addition
to having developmental roles, reduced Ntf3 expression in
the adult brain has been shown to be associated with defi-
cits in spatial learning, long-term potentiation impairments,
and increased anxiety-related traits [52-54]. Canonical path-
ways analysis indicated alterations to genes involved in en-
doplasmic reticulum (ER) stress response and such as the
downregulation of DnaJ (Hsp40) homolog, subfamily C,
member 3 (Dnajc3), also known as p58IPK. Cells showing
decreased expression of this molecular chaperone protein
are more prone to ER stress-induced apoptosis [55,56].
These results suggest that, beyond inducing cell death upon
immediate exposure, early gestational ethanol treatment
may lead to increased cellular vulnerability to other insults
in surviving adult neurons.
Ethanol exposure during trimester two affects genes
involved in cellular differentiation and migration
In contrast to E8/11 exposure, GO analysis of genes
affected by ethanol treatment at E14/16 revealed the alter-
ation of genes developmentally involved with cell migra-
tion, differentiation, and morphology (Table 2), processes
that occur rapidly during this developmental stage in many
brain regions [20,39,57]. Physiologically, ethanol exposure
during trimester two has been associated with abnormal
cell division and increased the appearance of radial-glia-
like precursors which dictate neural stem cell migration
from the ventricular zone (VZ) to the subventricular zone
(SVZ) during early differentiation [58,59]. This leads to the
depletion of certain susceptible cell types in the VZ and a
corresponding abnormal increase of cells in the SVZ and
may lead to the cortical heterotopias associated with
FASD. Interestingly, the homeobox transcription factors
distal-less homeobox 1 and 2 (Dlx1 and Dlx2) as well asdoublecortin (Dcx) were identified as altered in the adult
brain following E14/16 exposure. Dcx has been previously
implicated in alcohol’s effects on both the developing and
the adult brain [60-62], while Dlx1 and Dlx2 are the earli-
est Dlx genes to be expressed in the SVZ and are critical
regulators of interneuron differentiation and migration
in the developing telencephalon [63-65]. They are also re-
sponsible for the majority of GABAergic neurons in the
mammalian neocortex and are therefore crucial for the
regulation of the development of inhibitory neocortical cir-
cuitry [66,67]. IPA canonical pathway analysis also associ-
ated E14/16 exposure with changes to genes involved in
serotonin signaling (Table 3). Indeed, three serotonin recep-
tor subunits were identified as altered: 5-hydroxytryptamine
(serotonin) receptor 5A (Htr5a), Htr3a, and Htr6. Reduced
density of serotonin neurons have been previously associ-
ated with prenatal alcohol exposure [68-70]. Further, low
serotonin signaling, including that caused by neurodevel-
opmental alcohol exposure, has been implicated in a num-
ber of phenotypic outcomes relevant to FASD such as
increased impulsivity, aggression, hopelessness, explor-
atory activity, and risk for stress and anxiety-related traits
due to altered hypothalamic-pituitary-adrenal axis function
[71-75].
Early postnatal ethanol exposure altered genes
associated with synaptic function in the adult brain
Spanning approximately the first 2 weeks of postnatal
mouse development, the ‘brain growth spurt’ is a period
of extensive synaptogenesis and growth within the cortex,
hippocampus, and corpus callosum [18,20]. This stage of
development, equivalent to approximately the third trimes-
ter of human neurodevelopment [18,19], determines much
of the extent of the brain’s neural circuitry, including the
maintenance or pruning of synaptic connectivity in mul-
tiple brain regions. Disruptions to these processes, such as
by ethanol, may result in inappropriate synapse formation
and interfere with synaptic transmission, potentiation, and
plasticity in adulthood [76-79]. GO analysis of P4/7 ethanol
exposure suggested that many genes altered in the adult
brain by this treatment model were involved in biological
processes relevant to synaptic function. A number of
glutamate receptor subunits were identified, known to be
critical in the formation and maintenance of synapses, syn-
aptic plasticity, and long-term potentiation (LTP) [80-85].
Also of note is the downregulation of Eph receptor B1 and
B2 (Ephb1 and Ephb2), known to have classic functions in
axon guidance and brain region boundary formation [86]
as well as potentially controlling many other aspects of ex-
citatory synaptic transmission and plasticity [87-89]. Inter-
estingly, ethanol exposure at P4/7 also resulted in altered
steroid secretion due to the downregulation of both apoli-
poprotein E (Apoe) and proopiomelanocortin (Pomc), mol-
ecules that are essential for proper hypothalamic-pituitary
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with age-related neurodegeneration and cognitive decline
[90,91]. Phenotypically, Apoe null mice show increased
anxiety in the elevated plus maze but reduced activity in a
novel open field environment, which coincides with in-
creased plasma corticosterone levels and impaired per-
formance in spatial learning tests [90,92]. Contrastingly,
Pomc has been shown to be essential for postnatal adrenal
maturation, with Pomc null mice showing no production
of corticosterone [93]. Given this, it is certainly possible
that long-term alterations in the expression of these genes
may contribute to phenotypes such as cognitive abnormal-
ities and increased stress reactivity observed individuals
with FASD. The IPA canonical pathway analysis reflected
the results of the GO analysis, with genes associated with
glutamate receptor signaling and ephrin receptor signifi-
cantly represented. Genes associated with retinoic acid-
mediated apoptosis signaling were also altered, a finding
which is supported by other studies that report that pre-
natal ethanol exposure can lower retinoic ethanol receptor
function and elevate retinoic acid levels beyond normal
physiological levels [94-96]. Folate metabolism has also
been implicated in FASD phenotypes as folic acid supple-
mentation has been shown to ameliorate some of the ef-
fects of prenatal alcohol consumption [97,98]. Finally,
although it is known that the hypothalamus, including the
control of circadian ‘clock genes’, is disrupted by neuro-
developmental alcohol exposure [14,99,100], the identifica-
tion of circadian rhythm signaling is interesting given
that disturbed sleep patterns is a reported but relatively
unexplored consequence of fetal alcohol exposure. This
may be due to the disruption of corticotrophin-releasing
hormone neurotransmission due to abnormal synaptic
tract formation, but this potential consequence associated
with trimester three ethanol exposure requires further
investigation.
Common molecular pathways may mediate the effect of
ethanol on neurodevelopment despite execution through
trimester-specific gene sets
As a final part of this study, we conducted IPA network
analysis initially to evaluate further differences to adult
brain gene expression following ethanol treatment at
various neurodevelopmental stages. Evaluation of these
gene sets, however, revealed numerous similarities be-
tween gene networks. While each treatment was associ-
ated with somewhat different significant IPA networks,
the merged gene networks for each model revealed similar
sets of gene ‘hubs’ (Figures 4, 5, and 6). While these ‘hubs’
were not necessarily altered themselves, they linked dys-
regulated genes suggesting that there may be some com-
mon processes that remain altered into adulthood following
developmental ethanol exposure, regardless of timing.
Specifically, glutamate receptor subunits appeared as coremolecules in all treatment paradigms, as did many neu-
rotrophic molecules. Also, the developmentally-essential
gene Htt was associated with the altered gene networks of
each ethanol treatment model. This is, as far as we are
aware, unreported in prenatal alcohol exposure literature;
however, it is known that Htt has roles in cell survival, pro-
liferation, and migration [101,102]. Further, wild-type Htt
binds repressor proteins allowing the expression of critical
neuronal genes such as BDNF [103]. Despite this and its
well-established role in neuropathology, its relationship
with neurodevelopmental alcohol exposure remains an un-
explored avenue, and though its consistent appearance as
a hub here is intriguing, an explanation would only be
speculative.
Neurodevelopmental ethanol exposure and long-term
gene expression changes
Given that this study examined the long-term effects of
neurodevelopmental exposure to ethanol, it may be per-
tinent to ask what initiates and maintains these gene
expression changes over time. A clear answer to these
questions is not straightforward and may involve some
combination of the primary (acute) and secondary effects
of ethanol exposure. Factors that instigate these changes
in gene expression may include ethanol-induced apoptosis
of susceptible cell types, leading to an overall change in
the cellular composition of the brain and, subsequently,
the overall pattern of brain gene expression [27,32]. The
authors acknowledge that the use of whole brain tissue
makes this a possible reason for the results obtained by
this study. Also, it is important to note that, while the
genes identified may represent a broad response by the
neural transcriptome to ethanol, it would be expected
that various brain regions respond differently to ethanol
exposure given that developmental processes do not occur
uniformly and each region would have its own gene ex-
pression profile.
Another contributing mechanism may be the ability of
ethanol to disrupt developmental processes that are highly
reliant on external cues such as cell proliferation, migra-
tion, or differentiation [39,58,104]. These mechanisms
would represent immediate effects of alcohol that, during
adulthood, do not directly alter gene expression per se but
have altered cellular identity or physiology of the brain
such that the appropriate balance of neural gene expres-
sion is not maintained. This hypothesis has been sug-
gested for a number of spectrum disorders, and has been
referred to as a neurodevelopmental ‘footprint’ of terato-
gen exposure [15,105,106].
Finally, it is possible that there may be some factors that
maintain inappropriate gene expression at the molecular
level. Recent reports suggest that developmental ethanol
exposure can affect epigenetic patterning, particularly DNA
methylation and microRNA expression, which can produce
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a number of genes [107-111]. How these changes may
occur and how they are maintained is unknown, but this
hypothesis is certainly worth further investigating as it
would have implications towards the persistence of FASD
phenotypes throughout the life of an individual.
Conclusions
This study was initiated to provide a comparison of the
timing effects of neurodevelopmental ethanol exposure on
long-term changes in the brain transcriptome. The results
show that ethanol causes long-term molecular changes at
all developmental stages studied. Also, ethanol treatment,
regardless of timing, appears to cause a long-term disrup-
tion to genes associated with developmental processes that
are active at the time of exposure, resulting in a molecular
‘footprint’ of altered genes that perhaps reflects the most
susceptible biological networks at that developmental stage.
This disruption likely influences the resulting physiology of
the adolescent and adult brain and, subsequently, the phe-
notypes observed in the exposed individual. Not only does
this argue that timing is an important factor in determining
the variability and severity of FASD-related traits, but also
that knowledge of the developmental stage of exposure
may offer a modest predictive value towards the cognitive
and behavioral outcomes of an individual prenatally ex-
posed to alcohol. While future experiments are needed to
assess the mechanisms underlying the observed gene ex-
pression changes, including differences between distinct
brain regions and cell types, this model may provide an op-
portunity to evaluate some of the molecular processes that
suffer long-term changes from alcohol exposure at suscep-
tible neurodevelopmental times.
Additional file
Additional file 1: Table S1. Genes identified as differentially expressed
in the brain of adult mice following neurodevelopmental alcohol
exposure. Lists represent genes identified at P60 following ethanol
treatment at E8/11 (trimester 1), E14/16 (trimester 2), and P4/7 (trimester
3). Data included are gene-specific fold-changes and P-values.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MLK and KM performed all mouse work including injections and tissue
isolation. RNA extraction was performed by MLK, KM, and RLS. KM performed
mouse work, tissue isolation and extractions for trimesters 1 and 2. MLK
performed all array and pathway analyses. Gene confirmation was performed
by MLK, KM, and RLS. Manuscript was written by MLK with contributions
from KM and SMS. Project was developed by MLK, KM, and SMS. All authors
read and approved the final manuscript.
Acknowledgements
This work was supported by funding from the Queen Elizabeth II Scholarship
in Science and Technology (QEIISST) to MLK and grants from the Natural
Sciences and Engineering Research Council of Canada (NSERC), Canadian
Institutes of Health Research (CIHR), and the Ontario Mental HealthFoundation (OMHF) to SMS. The authors thank David Carter and the Robarts
Research Institute for their assistance and expertise with array hybridization.
Received: 2 November 2012 Accepted: 20 February 2013
Published: 13 March 2013
References
1. Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N: Fetal alcohol
spectrum disorder: Canadian guidelines for diagnosis. CMAJ 2005,
172:S1–S21.
2. Rasmussen C: Executive functioning and working memory in fetal alcohol
spectrum disorder. Alcohol Clin Exp Res 2005, 29:1359–1367.
3. Streissguth AP, O’Malley K: Neuropsychiatric implications and long-term
consequences of fetal alcohol spectrum disorders. Semin Clin
Neuropsychiatry 2000, 5:177–190.
4. Marchetta CM, Denny CH, Floyd RL, Cheal NE, Sniezek JE: Alcohol use
and binge drinking among women of childbearing age-United States,
2006-2010. MMWR Morb Mortal Wkly Rep 2012, 61:534–538.
5. Bertrand J, Floyd LL, Weber MK: Guidelines for identifying and referring
persons with fetal alcohol syndrome. MMWR Recomm Rep 2005, 54:1–14.
6. Lupton C, Burd L, Harwood R: Cost of fetal alcohol spectrum disorders.
Am J Med Genet C Semin Med Genet 2004, 127C:42–50.
7. Stade B, Ali A, Bennett D, Campbell D, Johnston M, Lens C, Tran S, Koren G:
The burden of prenatal exposure to alcohol: revised measurement of
cost. Can J Clin Pharmacol 2009, 16:e91–102.
8. Fast DK, Conry J: The challenge of fetal alcohol syndrome in the criminal
legal system. Addict Biol 2004, 9:161–166. discussion 167-8.
9. Famy C, Streissguth AP, Unis AS: Mental illness in adults with fetal alcohol
syndrome or fetal alcohol effects. Am J Psychiatry 1998, 155:552–554.
10. Nash K, Sheard E, Rovet J, Koren G: Understanding fetal alcohol spectrum
disorders (FASDs): toward identification of a behavioral phenotype.
ScientificWorldJournal 2008, 8:873–882.
11. Green ML, Singh AV, Zhang Y, Nemeth KA, Sulik KK, Knudsen TB:
Reprogramming of genetic networks during initiation of the Fetal
Alcohol Syndrome. Dev Dyn 2007, 236:613–631.
12. Hard ML, Abdolell M, Robinson BH, Koren G: Gene-expression analysis
after alcohol exposure in the developing mouse. J Lab Clin Med
2005, 145:47–54.
13. Zhou FC, Zhao Q, Liu Y, Goodlett CR, Liang T, McClintick JN, Edenberg HJ,
Li L: Alteration of gene expression by alcohol exposure at early
neurulation. BMC Genomics 2011, 12:124.
14. Chen CP, Kuhn P, Advis JP, Sarkar DK: Prenatal ethanol exposure alters
the expression of period genes governing the circadian function of
beta-endorphin neurons in the hypothalamus. J Neurochem 2006,
97:1026–1033.
15. Kleiber ML, Laufer BI, Wright E, Diehl EJ, Singh SM: Long-term alterations to
the brain transcriptome in a maternal voluntary consumption model of
fetal alcohol spectrum disorders. Brain Res 2012, 1458:18–33.
16. Toso L, Poggi SH, Abebe D, Roberson R, Dunlap V, Park J, Spong CY:
N-methyl-D-aspartate subunit expression during mouse development
altered by in utero alcohol exposure. Am J Obstet Gynecol 2005,
193:1534–1539.
17. Toso L, Roberson R, Woodard J, Abebe D, Spong CY: Prenatal alcohol
exposure alters GABA(A)alpha5 expression: a mechanism of alcohol-
induced learning dysfunction. Am J Obstet Gynecol 2006, 195:522–527.
18. Clancy B, Darlington RB, Finlay BL: Translating developmental time across
mammalian species. Neuroscience 2001, 105:7–17.
19. Dobbing J, Sands J: Comparative aspects of the brain growth spurt.
Early Hum Dev 1979, 3:79–83.
20. Dobbing J, Sands J: Quantitative growth and development of human
brain. Arch Dis Child 1973, 48:757–67.
21. Mantha K, Kleiber ML, Singh SM: Neurodevelopmental timing of ethanol
exposure may contribute to observed heterogeneity of behavioural
deficits in a mouse model of Fetal Alcohol Spectrum Disorder (FASD).
J Behav Brain Sci 2013, 3:85–99.
22. Hunt PS, Jacobson SE, Torok EJ: Deficits in trace fear conditioning in a rat
model of fetal alcohol exposure: dose-response and timing effects.
Alcohol 2009, 43:465–474.
23. Lipinski RJ, Hammond P, O’Leary-Moore SK, Ament JJ, Pecevich SJ, Jiang Y,
Budin F, Parnell SE, Suttie M, Godin EA, Everson JL, Dehart DB, Oguz I,
Holloway HT, Styner MA, Johnson GA, Sulik KK: Ethanol-induced face-brain
Kleiber et al. Journal of Neurodevelopmental Disorders 2013, 5:6 Page 17 of 19
http://www.jneurodevdisorders.com/content/5/1/6dysmorphology patterns are correlative and exposure-stage dependent.
PLoS One 2012, 7:e43067.
24. Barr HM, Bookstein FL, O’Malley KD, Connor PD, Huggins JE, Streissguth AP:
Binge drinking during pregnancy as a predictor of psychiatric disorders
on the Structured Clinical Interview for DSM-IV in young adult offspring.
Am J Psychiatry 2006, 163:1061–1065.
25. Schlessinger AR, Cowan WM, Gottlieb DI: An autoradiographic study of the
time of origin and the pattern of granule cell migration in the dentate
gyrus of the rat. J Comp Neurol 1975, 159:149–175.
26. Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, Tenkova T, Young
C, Olney JW, Muglia LJ: Apoptotic neurodegeneration induced by ethanol
in neonatal mice is associated with profound learning/memory deficits
in juveniles followed by progressive functional recovery in adults.
Neurobiol Dis 2004, 17:403–414.
27. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price
MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW: Ethanol-
induced apoptotic neurodegeneration and fetal alcohol syndrome.
Science 2000, 287:1056–1060.
28. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries
of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15.
29. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA:
DAVID: Database for Annotation, Visualization, and Integrated Discovery.
Genome Biol 2003, 4:P3.
30. da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 2009, 37:1–13.
31. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the
comparative C(T) method. Nat Protoc 2008, 3:1101–1108.
32. Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C:
Ethanol-induced apoptotic neurodegeneration in the developing C57BL/
6 mouse brain. Brain Res Dev Brain Res 2002, 133:115–126.
33. Young C, Olney JW: Neuroapoptosis in the infant mouse brain triggered
by a transient small increase in blood alcohol concentration. Neurobiol
Dis 2006, 22:548–554.
34. Fagerlund A, Heikkinen S, Autti-Ramo I, Korkman M, Timonen M, Kuusi T,
Riley EP, Lundbom N: Brain metabolic alterations in adolescents and
young adults with fetal alcohol spectrum disorders. Alcohol Clin Exp Res
2006, 30:2097–2104.
35. Jirikowic T, Olson HC, Kartin D: Sensory processing, school performance,
and adaptive behavior of young school-age children with fetal alcohol
spectrum disorders. Phys Occup Ther Pediatr 2008, 28:117–136.
36. Stade B, Beyene J, Buller K, Ross S, Patterson K, Stevens B, Sgro M, Ungar W,
Watson W, Koren G: Feeling different: the experience of living with
fetal alcohol spectrum disorder. J Popul Ther Clin Pharmacol 2011,
18:e475–485.
37. Dobbing J: The later growth of the brain and its vulnerability. Pediatrics
1974, 53:2–6.
38. Blakley PM, Scott WJ Jr: Determination of the proximate teratogen of the
mouse fetal alcohol syndrome. 2. Pharmacokinetics of the placental
transfer of ethanol and acetaldehyde. Toxicol Appl Pharmacol 1984,
72:364–371.
39. Rice D, Barone S Jr: Critical periods of vulnerability for the developing
nervous system: evidence from humans and animal models. Environ
Health Perspect 2000, Suppl 3:511–533.
40. Allan AM, Chynoweth J, Tyler LA, Caldwell KK: A mouse model of prenatal
ethanol exposure using a voluntary drinking paradigm. Alcohol Clin Exp
Res 2003, 27:2009–2016.
41. Kleiber ML, Wright E, Singh SM: Maternal voluntary drinking in C57BL/6J
mice: Advancing a model for fetal alcohol spectrum disorders.
Behav Brain Res 2011, 223:376–387.
42. McMurray MS, Williams SK, Jarrett TM, Cox ET, Fay EE, Overstreet DH, Walker
CH, Johns JM: Gestational ethanol and nicotine exposure: effects on
maternal behavior, oxytocin, and offspring ethanol intake in the rat.
Neurotoxicol Teratol 2008, 30:475–486.
43. Chang GQ, Karatayev O, Liang SC, Barson JR, Leibowitz SF: Prenatal ethanol
exposure stimulates neurogenesis in hypothalamic and limbic peptide
systems: possible mechanism for offspring ethanol overconsumption.
Neuroscience 2012, 222:417–428.
44. Dubois C, Naassila M, Daoust M, Pierrefiche O: Early chronic ethanol
exposure in rats disturbs respiratory network activity and increases
sensitivity to ethanol. J Physiol 2006, 576:297–307.45. Alati R, Al Mamun A, Williams GM, O’Callaghan M, Najman JM, Bor W: In
utero alcohol exposure and prediction of alcohol disorders in early
adulthood: a birth cohort study. Arch Gen Psychiatry 2006, 63:1009–1016.
46. Barde YA: Trophic factors and neuronal survival. Neuron 1989, 2:1525–1534.
47. Kirstein M, Farinas I: Sensing life: regulation of sensory neuron survival by
neurotrophins. Cell Mol Life Sci 2002, 59:1787–1802.
48. Genc B, Ozdinler PH, Mendoza AE, Erzurumlu RS: A chemoattractant role
for NT-3 in proprioceptive axon guidance. PLoS Biol 2004, 2:e403.
49. Je HS, Zhou J, Yang F, Lu B: Distinct mechanisms for neurotrophin-3-induced
acute and long-term synaptic potentiation. J Neurosci 2005, 25:11719–11729.
50. Chao MV: Neurotrophins and their receptors: a convergence point for
many signalling pathways. Nat Rev Neurosci 2003, 4:299–309.
51. Lykissas MG, Batistatou AK, Charalabopoulos KA, Beris AE: The role of
neurotrophins in axonal growth, guidance, and regeneration.
Curr Neurovasc Res 2007, 4:143–151.
52. Uys JD, Marais L, Faure J, Prevoo D, Swart P, Mohammed AH, Stein DJ,
Daniels WM: Developmental trauma is associated with behavioral
hyperarousal, altered HPA axis activity, and decreased hippocampal
neurotrophin expression in the adult rat. Ann N Y Acad Sci 2006,
1071:542–546.
53. Reus GZ, Stringari RB, Ribeiro KF, Cipriano AL, Panizzutti BS, Stertz L, Lersch
C, Kapczinski F, Quevedo J: Maternal deprivation induces depressive-like
behaviour and alters neurotrophin levels in the rat brain. Neurochem Res
2011, 36:460–466.
54. Shimazu K, Zhao M, Sakata K, Akbarian S, Bates B, Jaenisch R, Lu B: NT-3
facilitates hippocampal plasticity and learning and memory by
regulating neurogenesis. Learn Mem 2006, 13:307–315.
55. Zhao L, Rosales C, Seburn K, Ron D, Ackerman SL: Alteration of the
unfolded protein response modifies neurodegeneration in a mouse
model of Marinesco-Sjogren syndrome. Hum Mol Genet 2010, 19:25–35.
56. Yan W, Frank CL, Korth MJ, Sopher BL, Novoa I, Ron D, Katze MG: Control
of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-
induced molecular chaperone P58IPK. Proc Natl Acad Sci U S A 2002,
99:15920–15925.
57. Singer HS, Chiu AY, Meiri KF, Morell P, Nelson PG, Tennekoon G: Advances
in understanding the development of the nervous system. Curr Opin
Neurol 1994, 7:153–159.
58. Camarillo C, Miranda RC: Ethanol exposure during neurogenesis induces
persistent effects on neural maturation: evidence from an ex vivo model
of fetal cerebral cortical neuroepithelial progenitor maturation. Gene Expr
2008, 14:159–171.
59. Hansen DV, Lui JH, Parker PR, Kriegstein AR: Neurogenic radial glia in
the outer subventricular zone of human neocortex. Nature 2010,
464:554–561.
60. Stevenson JR, Schroeder JP, Nixon K, Besheer J, Crews FT, Hodge CW:
Abstinence following alcohol drinking produces depression-like behavior
and reduced hippocampal neurogenesis in mice.
Neuropsychopharmacology 2009, 34:1209–1222.
61. He J, Nixon K, Shetty AK, Crews FT: Chronic alcohol exposure reduces
hippocampal neurogenesis and dendritic growth of newborn neurons.
Eur J Neurosci 2005, 21:2711–2720.
62. Hansson AC, Nixon K, Rimondini R, Damadzic R, Sommer WH, Eskay R,
Crews FT, Heilig M: Long-term suppression of forebrain neurogenesis and
loss of neuronal progenitor cells following prolonged alcohol
dependence in rats. Int J Neuropsychopharmacol 2010, 13:583–593.
63. Eisenstat DD, Liu JK, Mione M, Zhong W, Yu G, Anderson SA, Ghattas I, Puelles
L, Rubenstein JL: DLX-1, DLX-2, and DLX-5 expression define distinct stages
of basal forebrain differentiation. J Comp Neurol 1999, 414:217–237.
64. Liu JK, Ghattas I, Liu S, Chen S, Rubenstein JL: Dlx genes encode
DNA-binding proteins that are expressed in an overlapping and
sequential pattern during basal ganglia differentiation. Dev Dyn
1997, 210:498–512.
65. Ghanem N, Andrusiak MG, Svoboda D, Al Lafi SM, Julian LM, McClellan KA,
De Repentigny Y, Kothary R, Ekker M, Blais A, Park DS, Slack RS: The Rb/E2F
pathway modulates neurogenesis through direct regulation of the Dlx1/
Dlx2 bigene cluster. J Neurosci 2012, 32:8219–8230.
66. Jones DL, Howard MA, Stanco A, Rubenstein JL, Baraban SC: Deletion of
Dlx1 results in reduced glutamatergic input to hippocampal
interneurons. J Neurophysiol 2011, 105:1984–1991.
67. Letinic K, Zoncu R, Rakic P: Origin of GABAergic neurons in the human
neocortex. Nature 2002, 417:645–649.
Kleiber et al. Journal of Neurodevelopmental Disorders 2013, 5:6 Page 18 of 19
http://www.jneurodevdisorders.com/content/5/1/668. Tajuddin NF, Druse MJ: In utero ethanol exposure decreased the density
of serotonin neurons. Maternal ipsapirone treatment exerted a
protective effect. Brain Res Dev Brain Res 1999, 117:191–197.
69. Schneider ML, Moore CF, Barr CS, Larson JA, Kraemer GW: Moderate
prenatal alcohol exposure and serotonin genotype interact to alter CNS
serotonin function in rhesus monkey offspring. Alcohol Clin Exp Res 2011,
35:912–920.
70. Sari Y, Zhou FC: Prenatal alcohol exposure causes long-term serotonin
neuron deficit in mice. Alcohol Clin Exp Res 2004, 28:941–948.
71. Hofmann CE, Ellis L, Yu WK, Weinberg J: Hypothalamic-pituitary-adrenal
responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in
female and male rats prenatally exposed to ethanol. Alcohol Clin Exp Res
2007, 31:345–355.
72. Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D, Geyer
MA, Hen R: Increased exploratory activity and altered response to LSD in
mice lacking the 5-HT(5A) receptor. Neuron 1999, 22:581–591.
73. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J,
Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on
depression: moderation by a polymorphism in the 5-HTT gene.
Science 2003, 301:386–389.
74. Higley JD, Linnoila M: Low central nervous system serotonergic activity is
traitlike and correlates with impulsive behavior. A nonhuman primate
model investigating genetic and environmental influences on
neurotransmission. Ann N Y Acad Sci 1997, 836:39–56.
75. Mehlman PT, Higley JD, Faucher I, Lilly AA, Taub DM, Vickers J, Suomi SJ,
Linnoila M: Low CSF 5-HIAA concentrations and severe aggression and
impaired impulse control in nonhuman primates. Am J Psychiatry 1994,
151:1485–1491.
76. Olney JW, Wozniak DF, Farber NB, Jevtovic-Todorovic V, Bittigau P,
Ikonomidou C: The enigma of fetal alcohol neurotoxicity. Ann Med 2002,
34:109–119.
77. Mameli M, Zamudio PA, Carta M, Valenzuela CF: Developmentally
regulated actions of alcohol on hippocampal glutamatergic
transmission. J Neurosci 2005, 25:8027–8036.
78. Puglia MP, Valenzuela CF: Ethanol acutely inhibits ionotropic
glutamate receptor-mediated responses and long-term potentiation
in the developing CA1 hippocampus. Alcohol Clin Exp Res 2010,
34:594–606.
79. Servais L, Hourez R, Bearzatto B, Gall D, Schiffmann SN, Cheron G:
Purkinje cell dysfunction and alteration of long-term synaptic
plasticity in fetal alcohol syndrome. Proc Natl Acad Sci U S A 2007,
104:9858–9863.
80. Kim MH, Choi J, Yang J, Chung W, Kim JH, Paik SK, Kim K, Han S, Won H,
Bae YS, Cho SH, Seo J, Bae YC, Choi SY, Kim E: Enhanced NMDA receptor-
mediated synaptic transmission, enhanced long-term potentiation, and
impaired learning and memory in mice lacking IRSp53. J Neurosci 2009,
29:1586–1595.
81. Cotman CW, Monaghan DT, Ganong AH: Excitatory amino acid
neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.
Annu Rev Neurosci 1988, 11:61–80.
82. Rabacchi S, Bailly Y, Delhaye-Bouchaud N, Mariani J: Involvement of the N-
methyl D-aspartate (NMDA) receptor in synapse elimination during
cerebellar development. Science 1992, 256:1823–1825.
83. Luthi A, Schwyzer L, Mateos JM, Gahwiler BH, McKinney RA: NMDA
receptor activation limits the number of synaptic connections during
hippocampal development. Nat Neurosci 2001, 4:1102–1107.
84. Gambrill AC, Barria A: NMDA receptor subunit composition controls
synaptogenesis and synapse stabilization. Proc Natl Acad Sci U S A 2011,
108:5855–5860.
85. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson
YP, Wang YT: Role of NMDA receptor subtypes in governing the
direction of hippocampal synaptic plasticity. Science 2004,
304:1021–1024.
86. Kullander K, Klein R: Mechanisms and functions of Eph and ephrin
signalling. Nat Rev Mol Cell Biol 2002, 3:475–486.
87. Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME:
EphB receptors interact with NMDA receptors and regulate excitatory
synapse formation. Cell 2000, 103:945–956.
88. Henkemeyer M, Itkis OS, Ngo M, Hickmott PW, Ethell IM: Multiple EphB
receptor tyrosine kinases shape dendritic spines in the hippocampus.
J Cell Biol 2003, 163:1313–1326.89. Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC, Pawson T:
The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic
function. Neuron 2001, 32:1041–1056.
90. Grootendorst J, Kempes MM, Lucassen PJ, Dalm S, de Kloet ER, Oitzl MS:
Differential effect of corticosterone on spatial learning abilities in
apolipoprotein E knockout and C57BL/6J mice. Brain Res 2002,
953:281–285.
91. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD:
Neurodegeneration in the central nervous system of apoE-deficient
mice. Exp Neurol 1995, 136:107–122.
92. Raber J, Akana SF, Bhatnagar S, Dallman MF, Wong D, Mucke L:
Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice:
possible role in behavioral and metabolic alterations. J Neurosci
2000, 20:2064–2071.
93. Karpac J, Ostwald D, Bui S, Hunnewell P, Shankar M, Hochgeschwender U:
Development, maintenance, and function of the adrenal gland in early
postnatal proopiomelanocortin-null mutant mice. Endocrinology 2005,
146:2555–2562.
94. Kane MA, Folias AE, Wang C, Napoli JL: Ethanol elevates physiological
all-trans-retinoic acid levels in select loci through altering retinoid
metabolism in multiple loci: a potential mechanism of ethanol toxicity.
FASEB J 2010, 24:823–832.
95. Kumar A, Singh CK, DiPette DD, Singh US: Ethanol impairs activation
of retinoic acid receptors in cerebellar granule cells in a rodent model
of fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2010,
34:928–937.
96. Grummer MA, Zachman RD: Prenatal ethanol consumption alters
the expression of cellular retinol binding protein and retinoic acid
receptor mRNA in fetal rat embryo and brain. Alcohol Clin Exp Res 1995,
19:1376–1381.
97. Xu Y, Tang Y, Li Y: Effect of folic acid on prenatal alcohol-induced
modification of brain proteome in mice. Br J Nutr 2008, 99:455–461.
98. Wang LL, Zhang Z, Li Q, Yang R, Pei X, Xu Y, Wang J, Zhou SF, Li Y: Ethanol
exposure induces differential microRNA and target gene expression and
teratogenic effects which can be suppressed by folic acid
supplementation. Hum Reprod 2009, 24:562–579.
99. Sakata-Haga H, Dominguez HD, Sei H, Fukui Y, Riley EP, Thomas JD:
Alterations in circadian rhythm phase shifting ability in rats following
ethanol exposure during the third trimester brain growth spurt. Alcohol
Clin Exp Res 2006, 30:899–907.
100. Earnest DJ, Chen WJ, West JR: Developmental alcohol and circadian clock
function. Alcohol Res Health 2001, 25:136–140.
101. Nasir J, Floresco SB, O’Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski
A, Marth JD, Phillips AG, Hayden MR: Targeted disruption of the
Huntington’s disease gene results in embryonic lethality and behavioral
and morphological changes in heterozygotes. Cell 1995, 81:811–823.
102. Tong Y, Ha TJ, Liu L, Nishimoto A, Reiner A, Goldowitz D: Spatial and
temporal requirements for huntingtin (Htt) in neuronal migration and
survival during brain development. J Neurosci 2011, 31:14794–14799.
103. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L,
MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S,
Cattaneo E: Loss of huntingtin-mediated BDNF gene transcription in
Huntington’s disease. Science 2001, 293:493–498.
104. Guerri C: Neuroanatomical and neurophysiological mechanisms involved
in central nervous system dysfunctions induced by prenatal alcohol
exposure. Alcohol Clin Exp Res 1998, 22:304–312.
105. Demjaha A, Maccabe JH, Murray RM: How genes and environmental
factors determine the different neurodevelopmental trajectories of
schizophrenia and bipolar disorder. Schizophr Bull 2011, 38:209–214.
106. Dufour-Rainfray D, Vourc’h P, Tourlet S, Guilloteau D, Chalon S, Andres CR:
Fetal exposure to teratogens: evidence of genes involved in autism.
Neurosci Biobehav Rev 2011, 35:1254–1265.
107. Kaminen-Ahola N, Ahola A, Maga M, Mallitt KA, Fahey P, Cox TC, Whitelaw
E, Chong S: Maternal ethanol consumption alters the epigenotype and
the phenotype of offspring in a mouse model. PLoS Genet 2010,
6:e1000811.
108. Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou FC: Alcohol exposure alters
DNA methylation profiles in mouse embryos at early neurulation.
Epigenetics 2009, 4:500–511.
109. Sathyan P, Golden HB, Miranda RC: Competing interactions between
micro-RNAs determine neural progenitor survival and proliferation after
Kleiber et al. Journal of Neurodevelopmental Disorders 2013, 5:6 Page 19 of 19
http://www.jneurodevdisorders.com/content/5/1/6ethanol exposure: evidence from an ex vivo model of the fetal cerebral
cortical neuroepithelium. J Neurosci 2007, 27:8546–8557.
110. Miranda RC: MicroRNAs and fetal brain development: implications for
ethanol teratology during the second trimester period of neurogenesis.
Front Genet 2011, 3:77.
111. Wang G, Wang X, Wang Y, Yang JY, Li L, Nephew KP, Edenberg HJ, Zhou
FC, Liu Y: Identification of transcription factor and microRNA binding
sites in responsible to fetal alcohol syndrome. BMC Genomics 2008,
Suppl 1:S19.
doi:10.1186/1866-1955-5-6
Cite this article as: Kleiber et al.: Neurodevelopmental alcohol exposure
elicits long-term changes to gene expression that alter distinct
molecular pathways dependent on timing of exposure. Journal of
Neurodevelopmental Disorders 2013 5:6.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
